Clinical Cases

Clinical Study of SarsCov-2 19 Nosode – Part 1: Sarscov-2 19 Nosode 30CK – Its Curative Effects in Patients with Covid 19

Clinical Study of SarsCov-2 19 Nosode - Part 1: Sarscov-2 19 Nosode 30CK - Its Curative Effects in Patients with Covid 19 1

Drs. Chetna N. Shukla and Amitrai Shah reports on a clinical study (10 cases) of the effectiveness of a nosode prepared from SarsCov-2 19. This sars covid nosode (SCN) is examined for its value in treating the Covid 19 disease. Subsequent articles will address the use of the nosode for post-covid sequelae and as a prophylactic for healthy individuals.

Part I: In 30 CK in Covid 19 Disease (10 Cases)

Part II: In post-Covid sequel (2 cases of ILF)

Part III:  In 06 CK in healthy humans

Cases from the Clinics of Dr Chetna N Shukla and Dr Amitrai Shah

Summary: In his August 2020 editorial Alan Schmukler wrote, Having been involved in homeopathy for some 30 years, and knowing that homeopaths are daily curing covid-19 patients, it is difficult for me to constantly read, “There are currently no effective treatments for covid-19”. This last statement is no longer true.

This is part one of a series of three articles:

Part 1 is s about evidence-based homoeopathy, depicting laboratory findings that are corrected by SarsCov-2 19 nosode in treatment of acute Covid 19 infection.

Part 2 is about evidence-based homoeopathy, depicting laboratory findings that are corrected by SarsCov-2 19 nosode in treatment of Post Covid sequel ( ILF- 2 cases)

Part 3 is about evidence-based homoeopathy, depicting the effect of SarsCov-2 19 nosode in 06CK on healthy human beings eliciting its effect on laboratory findings/ inflammatory markers related to the Covid 19 infection.

This protocol can be applied by any homoeopath to replicate these results. There are many homoeopaths all over India who are treating Covid 19. I urge all of them to maintain records and collectively we can release these as tangible proof of the efficacy of homoeopathy.

Keywords: Covid 19 disease, SarsCov-2 19 Nosode, Pandemic

I would like to begin the article by quoting an interview excerpt of Dr Bhushan Patwardhan, chairman of AYUSH R&D Task Force on Covid-19 dated August 28, 2020…

In an exclusive interview to The Print, Dr Bhushan Patwardhan, chairman of interdisciplinary AYUSH Research and Development Task Force on Covid-19, said:

Currently, we are in the evidence-based precision medicine era. As of now, there is no proven treatment for SARS-CoV-2 infection or Covid-19 in any medical system.” The task force that Patwardhan heads was constituted by the Ministry of AYUSH. “Current management of Covid-19 is largely based on experience and empirical evidence. Therefore, what is conventional and what is alternative is difficult to decide,” he said, adding that “when several allopathic drugs are being repurposed based on empirical evidence, there is no reason as to why safe AYUSH interventions are ignored”.

Sars Covid Nosode prepared from SarsCov-2 19, referred to as ‘SCN’ henceforth, was made by Dr Chetna N. Shukla, (B.H.M.S), homoeopath Mumbai, India on 15 June 2020.

NOSODE PREPARATION:  The SCN medicine was prepared on 15 June 2020 at the clinic of Dr Chetna N Shukla. The medicine was prepared from the combined oropharyngeal and nasopharnygeal swab of a male patient that who tested positive for the presence of SARS COV-2 RNA by Real time Qualitative PT-PCR Detection of 2019-NCOV RNA COVID  19 collected on 14 June 2020.

POTENCY AVAILABLE:

  1. Handmade – 06 CK 30 CK (Korsakov) in pills; Handmade 0/1 and 0/8 in Millesimal from my clinic (Dr Chetna N Shukla)
  2. All potencies will be available at a pharmacy in UK in a short while (will be announced later)

Clinical Study Team:

Clinical Study Team:   The team included myself and Dr Amitrai Shah from Surat.  He agreed to let me supervise and prescribe for cases from his clinic and follow directions of administering charted out by me.   

OBJECTIVES:

  • Study 1: In patients: To study the effect of SarsCov-2 19 Nosode (referred to as SCN henceforth) in 30Ck in disease of Covid 19 and sequelae.
  • Study 2: In healthy Humans: To study the effect of SCN in 06 Ck ( low potency) in healthy human beings ( Part III of article).

SHORT NOTE ON NOSODE, IMMUNIZATION & VACCINATION

Immunization and Vaccination are two different concepts.

Immunization is the natural process of developing immunity. Immunization happens when you get the viral disease or are exposed to the disease. As a result, your body builds up its own immunity by developing antibodies. Immunity can be for life and does not require booster shots.

It is stated that immune responses can also be produced by vaccines.  It is stated that vaccination confer an artificially acquired immunity to the specific viral infection. Vaccination is based on the idea of priming the immune system with the organism that’s been killed or attenuated and for it to develop antibodies. So, that next time you are exposed, your immune system reacts quickly and you don’t actually get sick.

If a person develops a positive antibody response following vaccination, that vaccination is stated to be successful. But none of the vaccinated individuals are ever tested for antibody titers/ levels in blood after getting vaccinated to examine the efficacy of that vaccine.

Examples: MMR vaccine  contains live measles, mumps and rubella viruses that have been weakened (attenuated) along with inactive ingredients: sorbitol, sucrose, hydrolyzed gelatin, recombinant human albumin, fetal bovine serum, other buffer and media ingredients, neomycin etc.

The BCG vaccine has a live culture preparation of the Bacillus of Calmette and Guerin (BCG) strain of Mycobacterium bovis, the TICE strain.  The medium in which the TICE- BCG organism is grown for preparation of the freeze-dried cake is composed of the following ingredients: glycerin, asparagine, citric acid, potassium phosphate, magnesium sulfate, and iron ammonium citrate. The small pox vaccine contains live vaccinia virus.

Vaccines contain pathogens

Vaccines work through the individual’s immune system and essentially rely on it to evoke a response for that individual to be protected. If your immune system is inefficient and does not get primed after vaccination, you are not protected.

The present pandemic of Covid- 19 is caused by a new virus. When a disease is new, there is no vaccine until one is developed. There is a global race among pharma industries to develop a vaccine as soon as possible. Seven Indian pharma companies are in a race to produce Covid vaccine as of July 2020, and 23 U.S. companies according to a US news report.

It can take considerable time to develop a new safe and effective vaccine. Meanwhile we all have to rely on our inherent immune system, immune boosting foods and practices (Yoga, Homoeopathy, Ayurveda etc.) based on our time-tested traditional knowledge. The AYUSH Ministry announced Arsenicum album 30 CK as an immune booster. This can be administered to a general population.

NOSODES

Nosodes (from the Greek nosos, disease) are biological preparations used in homeopathic medicine to prevent disease. The concept of Nosodes as therapy was advanced by our founder Dr Samuel Hahnemann (1755–1843). Nosodes are medicines derived from an element of a disease or from diseased tissue, defined as “a homoeopathically prepared remedy made from an infectious disease product either directly from the bacteria or virus, or less directly from a tissue purported to contain it”.

Nosodes are based on the same idea as the vaccine, but Nosodes cannot be classified as vaccines.  Nosodes are preparations made from pathogens, products of pathogens or pathologically altered tissue. These are potentised (attenuated) according to the Homeopathic Pharmacopoeia. Nosodes like all homoeopathic medicines are administered orally through an open system. Vaccines are administered hypodermically (injection) and the contents of the vaccine stay in circulation (which is a closed system).

Nosodes are more than 100 years old and have been utilized by homoeopaths effectively the world over since then. Psorinum, Medorrhinum, Syphillinum and Variolinum are some of the Nosodes.

Psorinum proved by Dr Constantine Hering in 1830, is prepared from the fluid of blisters from scabies infested skin. Medorrhinum is prepared from the urethral discharge of a patient having gonorrhoea. Syphilinum was prepared by Swan in 1880 from Syphilis.

Variolinum is the contents of the ripened pustule of smallpox. Small pox and measles viruses are among the oldest that infect humans. Small pox is believed to be eradicated. Until I prepared the SarsCov-2 19 Nosode I was utilizing the remedial effects of Variolinum 200 and 1M in my clinic during the Covid 19 pandemic along with the constitutional remedy of the patient.

Variolinum in my experience works as a broad spectrum anti-viral. It has been in use in homoeopathy for decades as a first form of defence in most viral infections. The best indicated medicine is a nosode specific to that pathogen (virus/ bacteria) responsible for the disease/ epidemic /pandemic.  

According to principles of Homoeopathy indications of Nosode/s are:

Genus epidemicus during an epidemic

  • Constitutional medicine based on symptom similarity
  • Preventive in susceptible individuals who exhibit symptoms that are an archetype of the disease
  • Anti-miasmatic to clear the miasma during and after the pandemic
  • Anti-misamatic for future generations who inherit the miasma through their parents who suffered the trauma of the epi/pandemic

There is ample clinical evidence in homoeopathy that Nosodes are safe and effective. But there is scanty recorded evidence regarding Nosodes correcting the abnormal laboratory tests (in Covid 19 infection we refer to inflammatory markers).

STUDY 1

Law of Similars: Study 1 aims at establishing that the Sars Cov-2 19 Virus that causes the Covid 19 disease is, in the potentized form (Nosode), capable of curing the disease that it can cause.

COVID-19, caused by SARS-CoV-2 RNA virus

Despite the fact that most cases have mild symptoms and a good prognosis, COVID-19 can develop into ARDS and even death.  In allopathic medicine, anti-inflammatory agents for COVID-19 therapy highlight the critical role of inflammation in the progression of COVID-19. In a study, it has been concluded that inflammatory markers, especially Neutrophil count, Lymphocyte count, CRP, PCT (Procalcitonin), IL-6, ESR, SGOT (AST), SGPT (ALT), LDH and Ferritin were positively correlated with the severity of COVID-19.

STUDY 1: THE CLINICAL TRIAL OF SarsCov-2 19 Nosode in 30 CK in patients of Covid 19   

INFLAMMATORY MARKERS UNDER STUDY  

Early recognition of susceptibility to COVID-19 infection is absolutely essential in times of pandemic and especially in older patients and those with pre-existing illness. Inflammatory markers such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Procalcitonin (PCT), Ferritin, and Interleukin-6 (IL-6) have been reported to be significantly associated with the high risks of the development of severe COVID-19 .

Certain affordable and available laboratory markers were used during the clinical study of SCN medicine…

  1. Blood  reports
  • CBC  reflecting Leucopenia, Lymphopenia, Leukocytosis, High Neutrophil count
  • CRP count: Raised
  • Ferritin levels: Raised
  • Liver enzymes: SGOT, SGPT & Lactate Dehydrogenase : Raised
  • Coagulation parameters: D-dimer : Raised
  • Procalcitonin in children : Raised
  • IL-6 ( Inter leukin -6)
  1. Chest Examination
  • Chest X ray
  • CT Scan where indicated
  • MRI scan where indicated
  1. SpO2 levels: Blood Oxygen levels via Oximeter in cases with symptoms of throat affection, breathlessness and lung involvement
  2. Other relevant investigations related to co-morbidity

THE PRESCRIPTION PLAN ACCORDING TO SYMPTOMS:

  1. SCN 30CK with Kali Mur 6x: Cases with presence of inflammatory markers without any individualizing symptoms to be prescribed on.
  2. SCN 30 CK along with Antim-ars 200: Cases with lung involvement (mild to moderate) along with presence of inflammatory markers. The potency and repetition to be adjusted depending on the change in symptoms/ change in X ray findings
  3. SCN 30 CK along with Antim- ars 200 or 1m and /or Ozone 200: Cases with lung involvement (moderate to severe) along with presence of inflammatory markers to be prescribed depending on indications. The potency and repetition to be adjusted depending on the change in symptoms/ change in X ray findings
  4. SCN 30 CK and Kali mur or Antim ars with Lachesis: Cases with high D-dimer along with co-morbidity and lung involvement
  5. SCN 30 CK with Pre-established constitutional: Cases with pre-existing illness
  6. Cases to be reviewed frequently, every 2 -3 days or depending on comfort and affordability of patient
  7. To prescribe the Simillimum if individualizing examination indicates another medicine other than those mentioned in above mentioned 1 to 6 criteria

Indications for Kali- mur: Kali mur in 6x is a tissue salt is known to assist the body in relief of symptoms of colds, sore throat and coryza.

Indications for Antim ars: As it is best indicated in cases of “Catarrhal Pneumonia associated with Influenza”- Pocket Manual of Homoeopathic Materia Medica & Repertory- By William Boericke

Indications for Ozone: Difficult respiration; cough with/ throat rawness/ deep respiration impossible. Not having enough air to breath, cannot take a deep inspiration. These symptoms are commonly present in ILF

Indications for Lachesis: There is risk of thrombosis and bleeding in the Covid 19 infection, depicted by D-dimer levels. Lachesis is for eliminating the risk of thrombosis and bleeding. It has been reported that abnormal D-dimer levels are associated with poor prognosis.

10 CASES TREATED WITH SarsCov-2 19 Nosode in 30 CK

Category A: Inflammatory markers indicating susceptibility to Covid 19

  • Case 1 : TD , Male , 34 years from Clinic of Dr Chetna Shukla  , Mumbai
  • Case 2: SV , Female , 50 years, from Clinic of Dr Chetna Shukla  , Mumbai
  • Case 3: SS , Female ,83 years from Clinic of Dr   Chetna Shukla  , Mumbai
  • Case 4: CS, Female, 21 years from Clinic of Dr Amitrai Shah , Surat
  • Case 5: PD , Male, 48 years from Clinic of Dr Amitrai Shah , Surat

Category B: Confirmed case of Covid 19 infection  

  • Case 6: KP, Female, 49 years from the Clinic of Dr Amitrai Shah, Surat ( X rays and reports scan attached)
  • Case 7: NM, Male 72 years, from the clinic of Dr Amitrai Shah , Surat
  • Case 8: LK, Female, 57 years, from Clinic of Dr Chetna Shukla, Mumbai
  • Case 9: MK, Male, 57 years, from Clinic of Dr Chetna Shukla  , Mumbai
  • Case 10: PR, Female 42 years from Clinic of Dr Chetna Shukla, Mumbai

Category C: Post Covid 19 ILF (Lung Fibrosis) is article Part II

  • Case 12/1-ILF: BS, Male 65 years, from Clinic of Dr Chetna Shukla, Mumbai
  • Case 13/2- ILF: AR, Male 48 years, from Clinic of Dr Chetna Shukla, Mumbai

Abbreviations: ND=Not done

Case 1

 Code: TD, Male, 34 years from Clinic of Dr   Chetna Shukla, Mumbai

Individual History: No co- morbidity

Date: 14 06 2020: Sore throat

Date: 15 06 2020: Sore throat with mild Fever

Date: 16 06 2020: Sore throat with Fever continuous 100 °F, spike of 103 °F . one spike at 11 p.m. Thirst for 3-4 bottles of water during the day. Exhausted

Date: 17 06 2020: Sore throat with Fever continuous 100 °F, spike of 103 °F . one spike at 6 a.m. Thirst for 3-4 bottles of water during the day. Rhinorrhea relieved by Tab Sinarest. Slight headache as in URTI > Sinarest . Loss of sense of smell- could not smell strong ginger in the ginger tea. Appetite normal. Loss of taste that came back in a day.

Date: 18 06 2020: Rhinorrhea and Slight headache as in URTI > Sinarest . Thirst for 3-4 bottles of water during the day . Appetite normal.

Date: 19 06 2020: Fever continuous 100 °F. Headache. Rhinorrhea better. No bodyache.  Better thereafter

17 June 2020 20 June 2020
WBC  ( 4000-11000) 4400  3700
Neutrophils  (40-80) 70 64
Lymphocytes (20-40) 18 26
Monocytes   (2-8 %) 11 8
CRP ( 1-10 mg/l) 19.1 7.8
SGOT ( 0-41) 43 ND
SGPT (0-41) 40 ND
LDH (135-225) 143 ND
Ferritin  (21.81-274.66) 116.08 ND
 Prescription:

Nosode SarsCov-2 19 in 30 CK only 1 pill taken on 19 June 2020 along with Kali mur 6x 2 pills three times for 7 days

Allopathy used by patient: Sinarest & Antipyretics

Conclusion: CRP corrected by the body with impetus from SarsCov-2 19 Nosode and Kali mur 6x

Case 2   

Code: SV , Female , 50 years, Homoeopath  from Clinic of Dr   Chetna Shukla  , Mumbai

Individual history: No co- morbidity Exposure to person/ relative suffering from SarsCov-2 19 Infection . Accompanied the relative for admission to hospital 2 days priori. Date 25 06 2020:  Throat congestion with severe pain since two days, painful deglutition even during water. Throat is red when I checked in mirror. Thirst nothing specific. Fever maximum 100.5. Severe body aches with headaches- frontal and temporal as if tightness. Don’t want anybody near me.

Adv: Natrum mur 200 I dose (Constitutional) repeat diluted in water if not better. But could not get the medicine. Nat mur not taken.

Date 26 06 2020 :  Unable to get blood reports done

Date 27 06 2020 : Persistent cough.  Fever with continuous headache

Medicines sent Sars Cov-2 19 Nosode 1 pill at bedtime. Natrum mur 200 2/2hrly for headache and Kali mur 6x 2 pills 2-3 times

Date 28 06 2020:  Feeling better than yesterday . Palpitations and weakness is present.  No fever. Sleeplessness, though appetite is better. Headaches are less – just comes for a while …then less, then comes back. Not persistent like yesterday.

Date 29 06 2020 :  Its been a week…I slept yesterday night for 5 hours at a stretch. Little cough, salty scanty sputum.  Left sided headache >. Only on right side. Appetite better.

27 June 2020 03 July 2020  
WBC  ( 4000-11000) 7000 6790
Neutrophils  (40-80) 55 48
Lymphocytes (20-40) 34 42.6
ESR -1 hour  (0-21) 31 10
CRP ( 1-10 mg/l) 32.8 3.8
SGOT ( 0-41) 20.9 ND
SGPT (0-41) 10.3 ND
LDH (135-225) 168 ND
Prescription:

Exposure to person/ relative suffering from SarsCov-2 19 Infection

Nosode SarsCov-2 19 in 30 CK only 1 pill taken on 27 June 2020 with  Kali mur 6x  2 pills twice daily for 7 days

Allopathy used by patient: Antipyretics

Conclusion: ESR and CRP corrected by the body with impetus from SarsCov-2 19 Nosode and Kali mur 6x

Case 3

Code:  SS , female , 83 years from Clinic of  Dr   Chetna Shukla  , Mumbai

K/C/O Chronic myelogenous Leukemia on medicine on Tab Hydra (Hydroxyurea ) -500mgm twice daily since 13 years. Her last report of CBC on 05 Nov 2019 maintained at WBC count:21700

Neutrophils: 89

Lymphocytes: 07

Individual History:

Date: 15 06 2020 : Vomiting with acidity – dark brown color.  Dizziness and goes to sleep and would vomit and also go to toilet. She had gone out to visit temple (Derasar) from outside as it is closed too. No other symptoms.

Date: 23 06 .2020 :  No vomiting No dizziness at all.  Appetite increased in morning and less after noon. Stool after eating anything only during lunch, not in evening.

15 June 2020 23 June 2020 30 June 2020
WBC  ( 4000-11000) 27,100 21,400 23190
Neutrophils  (40-80) 89 84 79
Absolute Neutrophil Count ( 2000-7000) 23577 17976 18320
Lymphocytes (20-40) 05 05 11
ESR -1 hour  (0-21) 11 27 29
CRP ( 1-10 mg/l) 7.63 19 8.78
SGOT ( 0-41)
SGPT (0-41) 12 ND ND
LDH (135-225) 529
Ferritin  (21.81-274.66) 67.10
D- Dimer (0.0 to 0.5) 0.55 0.53 0.60
Prescription:

In her case the Total WBC count is not a marker.

Nosode SarsCov-2 19 in 30 CK only 1 pill three times from 17.06 2020 for 4 days with Kali mur 6x  4 pills  daily for 7 days

On 24.06.2020 She was prescribed her constitutional Ficus religiosa 200/ 2 pills 2 hrly for 4 days as CRP had risen although she was symptomatically better along with Kali mur 6x

Allopathy used by patient: Tab Hydra ( 500mgm) twice daily for her pre-existing illness

Conclusion: CRP corrected by the body with impetus from  SarsCov-2 19 Nosode and Kali mur 6x

Case 4

Code: CS, Female, 21 years from Clinic of  Dr Amitrai Shah , Surat

Individual symptoms: No co- morbidity

1.      Complete loss of taste and smell since 1 week.

2.      Fever with chills at 4am followed by heat and perspiration

3.      Thirstless

4.      Severe Bodyache and Headache with prominent at temples both.

5.      Talking exhausts

6.      Breathless while talking and coughing.

7.      Coughing slight no prominent discharges

8.      Slightly constipated

9.      Weakness desire to lie down all the time

Completely recovered by 30 June 2020

25 June 2020 29 June 2020 06 July 2020
Hb (12-16) 12.6 12.5 12
WBC  ( 4000-11000) 4770 5160 8610
Neutrophils  (40-80) 60.2 41.2 58.9
Lymphocytes (20-40) 34.3 48.9 30.1
ESR -1 hour  (0-21) 42 35 35
CRP ( < 5 negative) 41.44 12.41 5.60
SGOT ( 0-41) 47.7 53 33
SGPT (0-41) 47.7 59.4 30.3
LDH (135-214) 261.33 320.57 214.18
Ferritin  (4.63-204) 69.20 56.13 21.14
X ray/ CT/ MRI Normal
Prescription:

Nosode SarsCov-2 19 in 30 CK  only 1 pill taken on 26 June 2020 along with Kali-mur 6x 2 pills tds.

Allopathy used by patient: Antipyretics

Conclusion: CRP, Leucocytes, Neutrophils, Lymphocytes, SGOT and SGPT corrected by the body with impetus from SarsCov-2 19 Nosode and Kali mur 6x

Case 5

Code:  PD , Male, 48 years  from Clinic of Dr Amitrai Shah , Surat

Individual symptoms No co- morbidity as on  22.June.2020

1.     Chilliness no fixed time.

2.     Body cold to touch but internally feels hot.

3.     Bitter taste of mouth. With thirst

4.     Loss of smell

Completely recovered by 27 June 2020

21 June 2020 27 June 2020 01 July 2020 15 July 2020
Hb 14.8 15 14.5 14.8
WBC  ( 4000-11000) 6640 6100 7700 6300
Neutrophils  (40-80) 71.1 50 63 58
Lymphocytes (20-40) 19.7 36 24 29
ESR -1 hour  (0-21) 46 13 07 6
CRP ( < 5 negative) 7.27 0.132

( range <0.5)

0.127

(range <0.5)

0.107

(range <0.5)

SGOT ( 0-41) 52.6  29 29 29
SGPT (0-41) 53.5 50 45 52
LDH (135-225) 183.26 170 181 171
Ferritin  (21.81 -274.66) 106.45 226.8 194.6 154
HRCT Normal
Prescription:

Nosode SarsCov-2 19 in 30 CK  only 1 pill taken on 23 June 2020 along with Kalimur 6x 2 pills tds

 Nosode SarsCov-2 19 in 30 CK  only 1 pill  repeat but diluted in 5th glass of water on 27 June 2020 continuing with Kali mur 6x 2 pills tds
Allopathy used by patient: Antipyretics

Conclusion: Neutrophilia, Lymphopenia,  SGOT, ESR and CRP corrected by the body with impetus from SarsCov-2 19 Nosode and Kali mur 6x

Case 6

Code: KP , Female 49 years , Detected with Pneumonia on  10 August 2020; From the Clinic of  Dr Amitrai Shah , Surat

Individual symptoms:  No co- morbidity

1.     Cough dry , No fever

2.     Loss of taste for tulsi but other tastes present ( ginger)

3.     Weakness with desire to lie down

4.     Bitter taste in mouth

5.     Thirst – small quantities

10 August 2020 14 August 2020 02 Sept 2020 s
WBC  ( 4000-11000)  –  6300 7100
Neutrophils  (40-80) 50 54
Lymphocytes (20-40) 40 40
ESR -1 hour  (0-21) 11 55
CRP ( < 5 negative) 5.3 4.6
 CT Scan Chest  Soft Patchy illdefined opacities in lower zones bilaterally, larger on right, may represent consolidation? P/O Viral Pneumonia e.g Covid likely Soft Patchy illdefined opacities in lower zones bilaterally,  represent Consolidation. As compared to previous X ray dated 10 8 2020 there is mild reduction in size of opacities Patchy illdefined opacities in lower zones bilaterally: resolving consolidations. As compared to X ray dated 10 08 2020 theer is marked reduction in size of opacities
Allopathy used by patient: Antipyretics

Prescription:

Nosode SarsCov-2 19 in 30 CK  only 1 pill taken on    10 August along with Antim ars 200 2 pills 3 times a day for 3 days

 Better – Taste returned, no weakness, cheerful, no cough as on 14 08 2020. X ray repeated .

Adv: SacrsCov-2 19 in 30 CK 1 pill for 2 days along with Antim ars for 2 more days

Post recovery she complained of weakness with sweating episodes . These were managed by Ferrum phos 6x and Calc phos 6x along with infrequent repetition of SCN 30 CK
Allopathy used by patient: Anti pyretics

Conclusion: CRP corrected and Xray opacities resolved by the body with impetus from  SarsCov-2 19 Nosode with Antim ars 200

 Case 7

Code: NM, Male 72 years, presented for Post Covid 19 treatment on 23 July 2020: From the clinic of Dr Amitrai Shah, Surat

Individual symptoms: K/c/o Hypertension with Diabetes

07 July 2020 10 July 2020 11 July 2020 13 July 2020 17 July 2020 29 July 2020
WBC  ( 4000-11000) 5420 10000 10700 9340 6610
Neutrophils  (40-80) 76 90 91 79 77
Lymphocytes (20-40) 17 07 05 15 18
ESR -1 hour  (0-21)
CRP ( < 10 negative) 70 27 19 6
LDH (135-225) 321
Ferritin  (21.81-274.66) 135.47 88.36
D- Dimer <500 2393.31 1254
Inter leukin -6 ( IL-6)

(0.0-      7.0)

74.27 4.14 <2.7
 PT-PCR SarsCov-2 RNA +ve          
 Potassium (3.5-5.1 nmol/l) 5.36 5.43 5.38 4.84 5.34
HRCT

07 July 2020

Multilple patches of GGO density consolidations with superimposed interlobular septal thickening through bilateral lung parenchyma most of them in subpleural location (40-50% lung involvement) (CORADS V- highly suspicious for Covid 19)
2-d Echo 08/07/20 Mild concentric LVH

EF 60%

X ray Chest

20  July 2020

Bilateral predominantly

Peripheral patchy opacities

X ray Chest

19 Aug 2020

Ill defined soft patchy opacities with linear band both mid and lower zones_ infective?  Cardiomegaly. Lt Ventricular dominance. Unfolding of aorta.

SpO2 maintained at 96-97

Allopathy used by patient: Antipyretics and Diabetes and Blood pressure medications

Prescription:

Nosode SarsCov-2 19 in 30 CK only 1 pill taken on 23rd July 2020 followed by Ozone 200/ 2 pills 2 hourly for 3 days

Ozone 1M- one pill given on 29 July 2020

Allopathy used by patient:

Conclusion: CRP, IL6, WBC count corrected by the body with impetus from SarsCov-2 19 Nosode and Ozone 200 prescribed up to 10M with no clinical symptoms and SpO2 maintained between 95-96, no breathlessness

He is continuing homoeopathic treatment for the residual lung findings on Ozone.

Case 8

Code: Mrs LK Female, 57 years – From clinic of Dr Chetna N Shukla

Individual symptoms: Operated for pituitary lesion, diabetic with depression – on antidepressants on treatment with homoeopathy – last medicine received was Lilium tig. The cook tested positive for Covid-19 and since he was a diabetic the following tests were advised for all family members

She did not suffer from any symptoms

11 August 2020 04 Sept 2020
Hb 11.7  11.2
WBC  ( 4000-11000) 4400  5300
Neutrophils  (40-80) 44 52
Lymphocytes (20-40) 40 38
ESR -1 hour  (0-21)  
CRP ( < 10 negative) 53  
SGOT ( 0-41) 22 18.7
SGPT (0-41) 24 12.3
GGTP <40 44 ND
D- Dimer0.0- 0.5 0.78 ND
HbA1C 7.3 6.0
Procalcitonin <0.5 -2 0.379 ND
 PT-PCR Detected ND
  Blood Sugar ND ND
Anti SarsCov 2 Antibodies   Reactive 9.720
Prescription: Nosode SarsCov-2 19 in 30 CK  only 1 pill for 5 days taken on   11 August 2020 followed by Kali mur 6x /2 pills tds for 1 week

(The delay in repeating blood tests was due to Ganesha festival celebrations at their home)

Conclusion:  CRP, Leucocytes, Neutrophils, Lymphocytes, SGOT and SGPT corrected by the body with impetus from SarsCov-2 19 Nosode and Kali mur 6x

Case 9

Code: Mr MK Male, 57 years – From clinic of Dr Chetna N Shukla

Individual symptoms: Diabetic on treatment with homoeopathy constitutional medicine Fluoric acid and Belladonna for acute conditions. Their cook tested positive for Covid-19 and since he was a diabetic the following tests were advised for all family members. He did not suffer from any symptoms.

11 August 2020 04 Sept 2020
Hb 10.6 10.6
WBC  ( 4000-11000) 6400 6100
Neutrophils  (40-80) 48 50
Lymphocytes (20-40) 44 43
ESR -1 hour  (0-21) ND 12
CRP ( < 10 negative) 18.20 7.07
SGOT ( 0-41) ND 37
SGPT (0-41) 57 58
GGTP <40 130 54
LDH (135-225) 239 134
Ferritin  (21.81-274.66) ND 155.50
D- Dimer0.0- 0.5 0.45
Inter leukin -6 ( IL-6) (0.0- 7.0) ND 3.48
HbA1C 7.8 6.5
Procalcitonin <0.5 -2 0.116
PT-PCR RNA detected
Anti SarsCov-2 Antibodies 8.340 Reactive
Blood Sugar  Fasting 146 140
Prescription:

Nosode SarsCov-2 19 in 30 CK  only 1 pill for 5 days taken on   11 August 2020 followed by Kali mur 6x /2 pills tds for 1 week

(-The delay in repeating blood tests was due to Ganesha festival celebrations at their home)

Case 10

Code: PR, female 44 years, years –  From clinic of Dr Chetna N Shukla

Individual symptoms: K/C/O Bronchial Asthma with Hypothyroidism on Tab Eltroxin50 mg along with joint pains and adult acne; ANA weakly positive 1:100 under homoeopathic treatment. She is the wife of case of ILF Code AR. Both tested positive together. Their 10-year old son tested negative.

Date: 13.06.2020: Telephonic conversation eliciting symptoms: Afternoon 1.30

1.     Dry cough for 5 days, fever and weakness

2.     Extremely anxious and in panic mode, nervous afraid what will happen and that she will be unable to breathe. Will have a tracheostomy tube again like she had years ago.

3.     Worried for her husband (AR), for her 10-year old son – what if he tests +ve?

4.     Nervous and crying, speaks very fast, cries while taking about her husband. “doctor I am positive but I have no symptoms, only dry cough. I have nobody to guide, tell me how to sanitize my son’s clothes, his stuff so that he is not infected. I am sending him to Dehradun to his grandparents” Tired of managing house, sanitizing etc

Date: 14.06.2020 : No symptoms other than mild cough . Report shows detection of Sars Cov-2 19 RNA

She was asymptomatic except for mild dry cough, extreme anxiety and fear. Her husband started having bloody sputum and was being admitted. She also got admitted in the same hospital as his for two reasons as she was too anxious to be alone at home –“What if something will happen to me?” and so that she could be close to him. Although she was not allowed in the ICU- she had information about his health on daily basis from the hospital staff.

13 June 2020 17 -18 June 2020 02 July 2020
Hb 11.8 10.8  
WBC  ( 4000-11000) 4600 4500  
Neutrophils  (40-80) 66 75  
Lymphocytes (20-40) 31 20  
ESR -1 hour  (0-21) 25 ND  
CRP ( < 10 negative) ND ND  
SGOT ( 0-41) ND 24  
SGPT (0-41) ND 20  
LDH (135-225) ND 157  
Ferritin  (21.81-274.66) ND 173.1  
D- Dimer <500 ND 336.94  
Inter leukin -6 ( IL-6)

7.0)

ND    
 PT-PCR Virus RNA Detected    
SpO2 levels ND    
 RBS 82.95    
X ray Chest    Normal  
Anti SarsCov-2     Reactive ( 49. 48)
Prescription:

On 13 June 2020June she was prescribed Calcarea carb 200 along with Kali mur 6x and Calc carb 1M sos .

On 17 06 2020: This day she got admitted. She was prescribed SarsCov2-19Nosode 30 CK that she took in the hospital for 3 days as she was in general ward and asymptomatic . She was discharged on 25- 06- 2020 .

Conclusion:

The Analysis…

  • Case 1: TD- No PEI-SCN 30CK with Kali mur prevented the further development of Covid 19 disease
  • Case 2: SV- No PEI-SCN 30CK with Kali mur prevented the further development of Covid 19 disease   
  • Case 3: SS- PEI- SCN 30CK with Kali mur prevented the further development of Covid 19 disease, needed impetus from constitutional remedy to recover completely
  • Case 4: CS- No PEI – SCN 30CK with Kali mur prevented the further development of Covid 19 disease
  • Case 5: PD- No PEI – SCN 30CK with Kali mur prevented the further development of Covid 19 disease
  • Case 6;- KP– No PEI – SCN 30CK with Antim ars treated the disease of Covid 19 in lungs   
  • Case 7: NM- PEI- SCN 30CK with Ozone treated the disease of Covid 19 in lungs     
  • Case 8: LK -PEI – SCN 30CK with Kali mur prevented the further development of Covid 19 disease
  • Case 9: MK- PEI- SCN 30CK with Kali mur prevented the further development of Covid 19 disease
  • Case 10: PR- PEI- Constitutional Calc carb with SCN 30CK with Kali mur prevented the further development of Covid 19 disease 

The Evaluation…

  1. SCN can be Preventive: Preventing the Covid 19 infection / disease by correcting the inflammatory markers in a short time without the disease extending to vital organs.
  2. SCN can be Curative: During infection in lungs
  3. SCN can be curative For Sequelae: For after effects of Covid 19 infection e.g. ILF, PTSD, post covid psychosis etc. (bringing into range the relevant abnormal laboratory findings)

OTHER INDICATIONS OF SarsCov-2 19 NOSODE

We are aware that war and conflict do not just affect the health and well-being of people who experience it directly. It can potentially have long term consequences for future generations. It is observed that children from war-torn areas of the globe are affected by trauma even before they are born.

The Covid-19 pandemic may have a traumatic effect not just on the health and well-being of people who lived through the pandemic, but it can have psychologically harming influence on children conceived and or born around these times. According to homoeopathic theory, such children may carry the Covid 19 miasma, and the SarsCov-2 19 nosode can help clear the miasma thus created.

I have not included cases of individuals with psychological impact and mental trauma including fear, anxiety, depression, panic, uncertainty etc. that benefited from the SarsCov-2 19 Nosode.

Special Note: More and more individuals are choosing homoeopathy to treat Covid 19 infections in our clinics and some are under exclusive homoeopathic treatment. We have other patients with ongoing treatment on the above-mentioned protocol.

These cases will be included in future articles.  I am also maintaining records of patients who  crossed over to hospitals for allopathy,  due to one of several reasons including : (1) regulations due to epidemic Laws, (2) tremendous fear manufactured around Covid 19 infection (3)  they requiring inpatient management due to co- morbidity and complications, (4) family pressure and anxiety.

I appreciate the excellent inpatient management system of allopathic system of medicine. In conjunction with their inpatient management this nosode has shown promising results in achieving freedom from Covid 19 in 2020.

Clinical Study of SarsCov-2 19 Nosode - Part 1: Sarscov-2 19 Nosode 30CK - Its Curative Effects in Patients with Covid 19 2

Clinical Study of SarsCov-2 19 Nosode - Part 1: Sarscov-2 19 Nosode 30CK - Its Curative Effects in Patients with Covid 19 3

Clinical Study of SarsCov-2 19 Nosode - Part 1: Sarscov-2 19 Nosode 30CK - Its Curative Effects in Patients with Covid 19 4

Clinical Study of SarsCov-2 19 Nosode - Part 1: Sarscov-2 19 Nosode 30CK - Its Curative Effects in Patients with Covid 19 5

References:  

  1. Association of inflammatory markers with the severity of COVID-19: A meta-analysis: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233226/#bib0135
  2. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study: https://www.ncbi.nlm.nih.gov/ pmc/articles/ PMC7130449/ pdf/aaem-8-e43.pdf
  3. Incorrect to call Ayurveda, homoeopathy alternative medicine for Covid — top AYUSH official https://theprint.in/health/incorrect-to-call-ayurveda-homoeopathy-alternative-medicine-for-covid-top-ayush-official/487377/
  4. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7233226/#bib0135
  5. MMR vaccine: https://vk.ovg.ox.ac.uk/vk/mmr-vaccine
  6. Ingredients MMR vaccine: wmerck.com› pi_circulars › mmr_ii › mmr_ii_ppi
  7. BCG vaccine: https://www.nhs.uk/conditions/vaccinations/bcg-tuberculosis-tb-vaccine /#:~:text=The%20BCG%20vaccine%20is%20made,without%20actually%20causing%20the%20disease.
  8. Ingredients of BCG: www.fda.gov › vaccines, blood & biologics › published
  9. Small Pox: https://www.livescience.com/60824-poxviruses-threat.html
  10. https://www.centerforhealthsecurity.org/our-work/publications/smallpox-fact-sheet#:~:text=Smallpox%20is%20a%20highly%20contagious,ever%20to%20be%20completely%20eradicated.
  11. https://health.economictimes.indiatimes.com/news/pharma/seven-indian-pharmaceutical-companies-race-to-develop-vaccine-for-deadly-coronavirus/77051473
  12. These 23 companies are working on coronavirus treatments or vaccines — here’s where things stand https://www.marketwatch.com/story/these-nine-companies-are-working-on-coronavirus-treatments-or-vaccines-heres-where-things-stand-2020-03-06
  13. International Journal of Infectious Diseases: https://www.science direct. com/ science/ article/pii/ S1201971220303623#:~: text= Inflammatory% 20markers %20such%20as% 20procalcitonin,et%20al.%2C%202020)
  14. Blood Reports: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC7194601/ #:~:text = C%2Dreactive%20protein%20(CRP),2020)%20(Table%201)
  15. Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286212/
  16. Mumbai Mirror 4 August 2020: [1]https://mumbaimirror.indiatimes.com/ coronavirus/ news/ cured-of-covid-22-return-to-kem-with-pulmonary-fibrosis/articleshowprint/ 77340422 .cms? prtpage=1
  17. Hindu Business: https://www.thehindubusinessline.com/news/world/90-of-recovered-covid-19-patients-in-wuhan-still-have-damaged-lungs-study/article32302989.ece#
  18. Tocilizumab: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243567/
  19. Tocilizumab: https://en.wikipedia.org/wiki/Tocilizumab
  20. Immunity passports in the context of COVID-19: https://www.who.int/news-room/ commentaries/detail/immunity-passports-in-the-context-of-covid-19?gclid=EAIaIQobChMIu9Pzjd-d6wIVCCQrCh2K0gHQEAAYASAAEgKwnPD_BwE
  21. Darlene A. Kertes: https://www.futurity.org/war-zones-stress-babies-1099502/
  22. https://www.who.int/water_sanitation_health/dwq/arsenicun5.pdf
  23. https://www.britannica.com/science/Avogadros-number
  24. Use of disinfectants: alcohol and bleach: https://www.ncbi. nlm.nih. gov/ books/ NBK214356/
  25. Interpreting Diagnostic Tests for SARS-CoV-2: Figure on : Estimated Variation Over Time in Diagnostic Tests for Detection of SARS-CoV-2 Infection Relative to Symptom Onset : https://pubmed.ncbi.nlm.nih.gov/32374370/

About the author

Dr Chetna N shukla

Dr Chetna N shukla

Dr Chetna N Shukla is a homeopath and author from Mumbai, India. She has written books on food and provings. Some of her works on provings have been translated into German, Czech and Portuguese. She has been conducting provings since 1996. She has conducted provings of new remedies of Peter Chappell and Harry van der Zee – the PC Cancer, PC Aids and PC Malaria and also the Indian Crow egg, Peacock egg, Indian Duck egg, Python, Indian Mongoose blood, Hippocampus kuda (Sea horse), Turtle shell, Red cap veiled tail gold fish, Armadillo hide (Tatu). In plants Cedrus odorata, Rudraksh, Mangifera indica; in flowers Rosa damask, Hibiscus rosasinensis, Crataegus, spiritual drink Ayahuasca as also Tailed jay butterfly, Donkey’s milk, Snowflakes and Shitake mushroom. She has been collating Global provings (Himalayan Salt, Natural Silver and Terra Indiana) – articles of which have been published in the Links. Apart from provings she has been practicing and working on the book on her concept of ‘Curability Quotient’ in homeopathy.

About the author

Amitrai Shah

Dr AmitRai Shah is a homoeopathic practitioner from Surat. He has studied with Dr Chetna Shukla and has a successful practise. He is also an honorary physician and a teacher of Organon at the Vyara Homoeopathic Medical College (Gujarat).

4 Comments

  • We are very proud of you chetna ji for your wonderful remedies and care. We are very happy taking medicine from almost 13years and happily living because of your medicine and care.and this pendamic you hv come up with the remedy of Covid 19 this is groundbreaking news for all India and abroad .may god bless you And our best regards Naveen Kumar

  • As a health provider I have joined a Canadian Facebook page called “Long Haulers Support Group Canada” to understand the symptoms and problems they are facing. Your work on the nosode is a ray of hope for all those suffering from post-COVID19 who are desperate to find a solution to the myriad of symptoms they are experiencing and for which conventional medicine has no answers and are constantly living in fear of never recovering. If you think it is appropriate, you may wish to join that group and share information as you see fit. I would also personally like to keep up with your research and find out how and where to obtain the nosode for my own patients. Thank you

  • Very interesting article and report. Thanks for publishing – and looking forward to when the SCN remedy may become available in the US.

  • DEAR DRS,
    WE ARE ALL PROUD OF YOUR INVENTION ON NOSODE OF SARS COV 19. HOMEOPATHY HAS AT-LEAST PROVED TO BE HEAD OF ALL PATHIES. AT THE SAME TIME WE ARE NOT HAPPY THAT MANUFACTURING OF THE NOSODE WAS GIVEN TO UK WHERE AS WE HAVE BEST MANUFACTURES IN INDIA ITSELF.
    THANKS &REGARDS
    DR C S GUPTA

Leave a Comment